New scoring system could cut Post-Transplant virus infections
NCT ID NCT07443501
First seen Mar 02, 2026 · Last updated May 01, 2026 · Updated 7 times
Summary
This study aims to reduce CMV infections in stem cell transplant patients by using a scoring system that measures immune recovery. The system will help doctors decide when to stop antiviral medication (letermovir) after transplant. The trial will enroll 1114 participants and track infection rates and side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMV INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.